Axogen, Inc.
AXGN· Nasdaq
Released Nov 1, 2017, after the close
10-Q filed Nov 1, 2017, 32 days after period end · 0001558370-17-007934
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $16.05M | $11.21M | $8.15M | $4.67M |
| Net Income | -$2.12M | -$2.31M | -$2.98M | -$3.24M |
| EPS Diluted | -$0.06 |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.11 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.